Novosibirsk · Russian-qualified counsel Recognised by Pravo-300 · Best Lawyers · Kommersant
Corporate & Regulatory

Client alert: Russian development affecting JSC vs LLC governance comparison for foreign investors in Russia in the pharmaceuticals sector

Stanislav Lastovsky · October 2026 · 3 min read

Russian JSC vs LLC rules differ on licence-holding and foreign shareholder rights in the pharmaceutical sector in material ways. Make an enquiry.

Alert: Russian development affecting JSC vs LLC governance for foreign investors in the pharmaceuticals sector Effective: October 2027

Russian regulatory practice has shifted in a way that directly affects foreign-owned pharmaceutical businesses structured as either a joint-stock company (JSC) or limited liability company (LLC) under Russian law. The Federal Service for Health Surveillance (Roszdravnadzor) has increasingly treated compliance with corporate governance requirements specific to each legal form as a precondition for the renewal and maintenance of pharmaceutical licences — a standard that was not consistently applied in earlier regulatory cycles.

Foreign shareholders in Russian pharmaceutical entities should be aware that JSCs and LLCs carry materially different governance obligations under Russian corporate legislation. JSCs are subject to mandatory disclosure of the shareholder register, external audit requirements that apply regardless of size, and more prescriptive rules governing shareholder voting rights and extraordinary general meetings. LLCs carry fewer mandatory disclosure obligations but impose participatory-consent requirements on share transfers that can create practical constraints on restructuring or exit. Where a corporate governance obligation is found to be unmet at a licensing checkpoint — including incomplete shareholder register maintenance for a JSC, or a defective participants' decision record for an LLC — Roszdravnadzor has in recent practice treated this as a ground to withhold renewal pending rectification. For a multinational group whose Russian subsidiary holds pharmaceutical licences critical to its distribution operations, a compliance gap of this nature can interrupt supply chain continuity without prior warning.

Recommended action:

Verify that your Russian pharmaceutical entity's corporate governance records are current and compliant with the requirements applicable to its specific legal form — JSC or LLC — under Russian corporate law.Review the shareholder register (for JSCs) or the participants' list and decision records (for LLCs) to confirm they accurately reflect the current ownership structure, including any post-reorganisation changes.Consult with Russian counsel before the next Roszdravnadzor licence renewal window to identify and address any gaps that could be treated as a compliance deficiency at the regulatory review stage.

For context on the underlying JSC vs LLC governance comparison, see Court practice shift on JSC vs LLC governance and Key risk points in JSC vs LLC governance. The firm's Corporate Governance practice advises foreign shareholders on entity-form compliance across regulated sectors.

To discuss your entity's governance compliance position before the next renewal cycle — contact: info@vetrovpartners.com |

— Stanislav Lastovsky Senior Lawyer, Practice Lead — Restructuring & Insolvency, Vetrov & Partners vetrovpartners.com/lastovsky/

**

Practitioner note

This briefing is general information and does not constitute legal advice. For advice on a specific matter, write in confidence to info@vetrovpartners.com.

Facing a matter like this?

Our team advises foreign clients on exactly these questions across Russia and the EAEU region. Initial 30-minute consultation — complimentary.

Make an enquiry